Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Tag | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
MC4R (melanocortin-4 receptor) is a class of peptides secreted by the ventromedial nucleus of the hypothalamus and is one of the five subtypes (MC1-5R) of the melanocortin receptor family. MC4R binds to the natural endogenous ligand α-melanocyte stimulating hormone (α-MSH) secreted by the brain, inhibiting the increase in body weight.
The Role of MC4R
MC4R is abundantly present in various regions of the animal's central nervous system, including the cerebral cortex, thalamus, hypothalamus, brainstem, and notochord. In mammals, MC4R has the function of mediating leptin and is an important signal molecule that regulates energy balance and energy homeostasis. MC4R can be combined with its endogenous ligand melanocortin (MC) or agouti protein (agouti protein) and agouti related protein (AGRP) to control appetite and body weight. It plays a key role in steady state.

Figure 1. The hypothalamic melanocortin system. (Girardet, et al. 2014)
The central nervous system's body weight regulation function of MC4R is mainly to inhibit food intake, resulting in lower blood sugar, insulin and leptin levels, thereby reducing body fat and reducing body weight. Therefore, MC4R has received much attention as an important regulatory factor in human obesity studies. Recent studies have shown that there is a correlation between the G→A mutation at the 1232 site of MC4R and the thickness of the sheep's backfat, and the AG and AA models have higher backfat thickness than the GG model. Studies have shown that MC4R is a dominant receptor subtype in neural tissue, especially in the hypothalamus, and therefore it is thought to play a key role in appetite control in the hypothalamus.
MC4R Adjustment
Melanocortin (MC) is a generic term for α-MSH, β-MSH, γ-MSH and ACTH. The precursor substance, which is produced by hydrolysis of proopiomelanocortin (POMC). Injecting α-MSH and its congener MT-II into the lateral ventricle of mice (a strong agonist of MC3R and MC4R) can inhibit the increase in food intake in mice during normal fasting and neuropeptide Y (NPY) stimulation. It also inhibits the overexpression of agouti (rat eggs) and ob/ob (lack of leptin) in obese mice. In mice that knocked out the MC4R gene, there was no response to the appetite-suppressing agonist MT-II, confirming that the regulation of endogenous MSH on food intake was achieved by MC4R. Studies have shown that antagonizing the binding of αMSH to MC4R in the hypothalamic feeding center increases the food intake of mice by 10% to 36% compared with the control group, reduces the heat production, increases the utilization rate of calories, and gradually becomes obese, and the body length is also increase.
MC4R and Obesity
MC4R is the first target site found to be associated with human dominant genetic disease obesity. The importance of MC4R in human energy and body weight regulation was gradually revealed after Yeo et al. and Vaisse et al first discovered MC4R gene translocation mutations in two patients with early-onset obesity. It is estimated that 1% to 4% of the extremely obese people with a BMI greater than 40 are due to mutations in the MC4R gene. Studies have shown that mice that knocked out the MC4R gene (MC4R-/-) developed genetic obesity and showed symptoms such as polyphagia, obesity, and excessive insulin secretion.
In humans, obesity caused by mutations in the MC4R gene has a variety of phenotypes, and is not accompanied by other endocrine and metabolic abnormalities other than polyphagia and obesity. The thyroid, adrenal gland, and reproductive function are normal, unlike other types of single-gene mutational obesity. In addition, the polymorphism of MC4R may also be related to body fat distribution and lipid metabolism. The obesity caused by body defect MC4R is adolescent, and the severity of women is higher than that of men. Most of them have a feminine tendency to distribute body fat.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.